Advanced clinical trials of the Oxford and AstraZeneca coronavirus vaccine have been suspended due to “an unexplained disease in one of the trials,” drug manufacturer AstraZeneca announced Tuesday.
The corporation called the lawsuit a “routine action” in a statement.
“Our popular review procedure has been initiated and we have voluntarily suspended vaccination to allow review of protection knowledge through an independent committee,” he said.
“In giant trials, diseases will happen by chance, but they will have to be independently tested to determine this carefully,” he continued. schedule. We are committed to ensuring the protection of our participants and the highest standards of conduct in our trials. “
Two other vaccines, one made through Moderna and the other through Pfizer and BioNTech from Germany, are in the final stages of testing in the US. But it’s not the first time Both vaccines are more than AstraZeneca’s, and studies have already recruited about two-thirds of the necessary volunteers.
Temporary suspensions of primary medical studies are not unusual, and research into any serious or unforeseen reaction is a mandatory component of protective testing. AstraZeneca is under pressure that the challenge is possibly a coincidence; diseases of all kinds can occur in studies of thousands of people.
The progression came on the same day that AstraZeneca and 8 other drug brands jointly pledged not to rush vaccination until it was proven and effective.
The union was launched through the CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson
“We, the biopharmaceutical companies below signatories, obviously want to make explicit our ongoing commitment to present and test possible vaccines opposed to COVID-19 according to the highest moral criteria and sound clinical principles,” he said.
The promise comes less than two weeks after the Centers for Disease Control and Prevention notified fitness officials in all 50 states and five major cities to prepare to distribute a coronavirus vaccine around 1 November, two days before Election Day. Donald Trump may pressure companies and fitness officials to speed up the launch of a vaccine and score political points.
Meanwhile, a recent USA Today/Suffolk vote found that despite 6. 3 million cases of coronavirus and nearly 190,000 deaths in the United States, two-thirds of Americans say they will not get the vaccine as soon as it becomes available.
The United States has invested billions of dollars in efforts to expand several vaccines opposed to COVID-19, but public fears that a vaccine is uncertain or useless may simply be disastrous and derail efforts to vaccinate millions of Americans.
FDA officials did not respond to requests for comment Tuesday night.
The Associated Press contributed to the report.